Abstract 4365505: Associations Between Calcium-Phosphate Ratio and Blood Pressure in Non-CKD Populations
Abstract
Introduction: Serum calcium, phosphate, and their interaction have been linked to vascular calcification. While high calcium-phosphate ratio (Ca/P) has been associated with adverse cardiovascular outcomes especially in chronic kidney disease (CKD), its relationship with blood pressure in non-CKD remains unclear. This study aims to assess the association between Ca/P and blood pressure in individuals without CKD. Methods: A retrospective cross-sectional analysis was conducted using data from the 2017–2020 NHANES. Mean systolic blood pressure (SBP) and diastolic blood pressure (DBP) were calculated from 3 consecutive blood pressure measurements. Ca/P was calculated by dividing serum calcium by serum phosphate (mg/dL) and categorized into quartiles. Estimated glomerular filtration rate (eGFR) was calculated using the CKD-EPI formula, with non-CKD defined as eGFR ≥ 60 mL/min/1.73 m 2 . Associations of serum calcium, phosphate, and Ca/P with SBP and DBP were assessed using multiple linear regression models, adjusting for demographics, comorbidities, laboratory values, average sodium and alcohol intake, and socioeconomic status. Result: Among the 4,621 adults included, mean age±SD was 51±17 years and 91.6% was non-CKD. The mean SBP and DBP were 124±19 and 75±11mmHg, respectively. The mean serum calcium and phosphate were 9.3±0.4 and 3.6±0.5 mg/dL, and the median [IQR] Ca/P was 2.6 [2.4–2.9]. In the fully adjusted models, serum Ca/P and calcium were positively associated with mean SBP and DBP while serum phosphate showed an inverse association (all p<0.05). When Ca/P was categorized into quartiles, Q3 and Q4 were graded associated with higher SBP (aβ SBP-Q3 2.31 (0.97-3.65) p<0.01, aβ SBP-Q4 2.79 (1.39-4.19) p<0.01) and DBP (aβ DBP-Q3 1.35 (0.51-2.20) p<0.01, aβ DBP-Q4 1.71 (0.82-2.59) p<0.01). In subgroup analysis of non-CKD, Ca/P in Q3 and Q4 showed stronger associations with both higher SBP (aβ non-CKD/SBP-Q3 2.64 (1.31-3.67) p<0.01, aβ non-CKD/SBP-Q4 3.29 (1.89-4.69) p<0.01) and DBP (aβ non-CKD/DBP-Q3 1.42 (0.55-2.28) p<0.01, aβ non-CKD/DBP-Q4 1.80 (0.90-2.70) p<0.01). Conclusion: Our study demonstrated that higher Ca/P is associated with elevated blood pressure, even in individuals without CKD. This hilights the need for further investigation into the interaction between serum calcium and phosphate in the non-CKD populations.
Article Details
Authors (26)
Panchanit Yongkiatkan
University of California Irvine School of Medicine, Orange, California, United States
Napat Wongmat
University of California Irvine School of Medicine, Orange, California, United States
Natanon Chamnarnphol
University of California Irvine School of Medicine, Orange, California, United States
Weerinth Puyati
University of California Irvine School of Medicine, Orange, California, United States
Nicha Wareesawetsuwan
University of California Irvine School of Medicine, Orange, California, United States
Sorawis Ngaohirunpat
Faculty of Medicine, Siriraj Hospital, Mahidol University, Bangkok, Thailand
Wanprapit Noree
University of California Irvine School of Medicine, Orange, California, United States
Nopavit Mohpichai
Mahidol University, Bangkok, Thailand
Vishwaas Gangeddula
University of California Irvine School of Medicine, Orange, California, United States
Seonghyeon Kim
Monique Massihians
Joe C. Wen School of Population&Public Health, University of California Irvine, Irvine, California, United States
Mary Lapadjyan
Joe C. Wen School of Population&Public Health, University of California Irvine, Irvine, California, United States
Christine Shahnazarian
Joe C. Wen School of Population&Public Health, University of California Irvine, Irvine, California, United States
Yangjiayi Liu
Joe C. Wen School of Population&Public Health, University of California Irvine, Irvine, California, United States
David Park
University of California Irvine School of Medicine, Orange, California, United States
Meghan Ho
Joe C. Wen School of Population&Public Health, University of California Irvine, Irvine, California, United States
Bahaar Ghaffarian
University of California Irvine School of Medicine, Orange, California, United States
Sarah Lee
Department of Neurology and Neurological Sciences, Stanford University School of Medicine, Stanford, CA
Vanessa Le
University of California Irvine School of Medicine, Orange, California, United States
Possawat Vutthikraivit
University of California Irvine School of Medicine, Orange, California, United States
Issaree Bunyawannukul
University of California Irvine School of Medicine, Orange, California, United States
Chutawat Kookanok
Narathorn Kulthamrongsri
University of California Irvine School of Medicine, Orange, California, United States
Phuuwadith Wattanachayakul
University of California Irvine School of Medicine, Orange, California, United States
Kyunghee Lee
University of California Irvine School of Medicine, Orange, California, United States
Ekamol Tantisattamo
University of California Irvine School of Medicine, Orange, California, United States